Acrylamide ERP Resubmission Review

For accuracy purpose, we modified the part G.e mentioning that we used the 2002/657/EC document to establish the identification criteria. Still, we added a note about the two recent documents that can also be taken as reference. To point out that identification criteria have been recently revised in EU Commission Decision 2021/808 [15] or in Document N° SANTE/11312/2021 [16] which can also be taken as reference for setting dentification criteria. For spike recovery calculations, was marginal recovery calculation used on all occasions? If total recovery calculation was used, this should be indicated in relevant tables. Part H.c Performance characteristics\Validation has been deeply modified. Calculations are displayed to provide more clarity. Reviewer 4: All comments were addressed in the previous pages.